Profile: Hancock Jaffe Laboratories, Inc. develops tissue-based solutions designed to help patients with peripheral vascular and end-stage renal diseases. Our product includes ProCol® vascular bioprosthesis. Our ProCol® bioprosthesis is a natural biological graft derived from a bovine mesenteric vein. The product is flexible, easy to suture and exhibits physiologic pulsatile flow characteristics similar to a native fistula. The graft may be implanted in a straight or loop configuration, according to the specific surgical need. It has demonstrated clinical efficacy in the upper arm, forearm and thigh. The hemodialysis access grafts are available in 6 mm diameter and a variety of different lengths to meet individual patient requirements. Our product is biocompatible and elicits no antibody reactions.
FDA Registration Number: 3008142729
3 Products/Services (Click for related suppliers)
|
• Biological Vascular Graft |
• Bioprosthesis, Pulmonary Valved Conduit |
• Tissue Graft (FDA Code: LXA) |